Ascendis Pharma A/S ( ASND) - Key Metrics
ASND Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q1 | $4.06 | $10.37 | -$0.13 | -$0.25 |
| 2025Q4 | $3.99 | -$0.54 | $1.15 | $1.10 |
| 2025Q3 | $3.50 | -$1 | $0.04 | $0.03 |
| 2025Q2 | $2.61 | -$0.64 | -$0.12 | -$0.19 |
| 2025Q1 | $1.68 | -$1.58 | -$0.24 | -$0.25 |
ASND Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q1 | 0% | 4.77 |
| 2025Q4 | 0% | -84.02 |
| 2025Q3 | 0% | -42.35 |
| 2025Q2 | 0% | -57.21 |
| 2025Q1 | 0% | -22.79 |
ASND
Price: $230.05
52 week price:
Earnings Per Share: 12.96 USD
P/E Ratio: 19.20
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Country: Denmark
Volume: 126716
Ebitda: -36.5 millionMarket Capitalization: 16.8 billion